S&P rates Amdipharm loans B+, B

Standard & Poor's said it assigned its B long-term corporate credit rating to Amdipharm Mercury Debtco Ltd. (AMCO)

The outlook is positive.

The agency also assigned a B+ issue rating and 2 recovery rating to AMCO's existing senior secured bank facilities.

At the same time, these ratings were placed on CreditWatch with negative implications.

S&P also assigned a B issue rating and 3 recovery rating to AMCO's proposed senior secured bank facilities. The B rating is derived from the agency’s anchor of b, which is based on its assessment of the company's "fair" business risk profile and "highly leveraged" financial risk profile. No modifiers affect the rating outcome.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.